A small UCSF study has found that a combination of vaccines, antibodies, and immune-activating drugs helped some HIV-positive individuals maintain low viral loads even after stopping ART. While promising, experts say larger trials are needed before calling it a path to a functional cure.
No comments:
Post a Comment